My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

OKYO Pharma Limited - Ordinary Shares (NQ:OKYO)

1.750 -0.420 (-19.35%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about OKYO Pharma Limited - Ordinary Shares

< Previous 1 2 3 4 5 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 14, 2023

It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition? ↗

May 30, 2023

The Japanese healthcare company Astellas Pharma, Inc. (OTC: ALPMF) recently announced its acquisition of the biopharmaceutical company Iveric Bio

Via Benzinga

Phase 2 Trials Begin For Promising New Dry Eye Disease Treatment From OKYO Pharma ↗

May 12, 2023

Dr. Gary S. Jacob, CEO of OKYO Pharma (NASDAQ: OKYO), was recently a guest on Benzinga’s All Access.

Via Benzinga

Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket ↗

May 09, 2023

Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday.

Via Benzinga

Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 10, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.

Via Benzinga

OKYO Pharma Reports First Patient Visit For Phase 2 Trial Of OK-101, To Fulfill One Of The Two Phase 3 Studies Required For FDA Approval If Successful ↗

May 03, 2023

OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced that the first patient has been screened for its phase 2, multicenter, randomized, double-blinded, placebo-controlled trial, evaluating the...

Via Benzinga

Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 08, 2023

Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.

Via Benzinga

OKYO Pharma Activates First Clinical Trial Site For Phase 2 Study Of OK-101 To Treat Dry Eye Disease ↗

April 26, 2023

OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced the activation of the first clinical trial site in the U.S. for its phase 2, multi-center, randomized, double-blinded, placebo-controlled trial,...

Via Benzinga

OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay ↗

April 18, 2023

Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).

Via Benzinga

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4

March 28, 2023

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4

Via News Direct

OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4 ↗

March 28, 2023

Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...

Via Benzinga

OKYO Pharma's Trial Treating Subjects With DED Gets Listed On ClinicalTrials.gov ↗

March 17, 2023

OKYO Pharma Limited (LSE: OKYO) (NASDAQ: OKYO) announced that its planned trial evaluating the efficacy and safety of OK-101 in subjects with DED has been posted on the ClinicalTrials.gov public...

Via Benzinga

Why Is Okyo Pharma (OKYO) Stock Up 13% Today? ↗

March 16, 2023

Okyo Pharma (OKYO) stock is on the rise Thursday as investors react to news about its Phase 2 clinical trial of DED treatment OK-101.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 14, 2023

Via Benzinga

UBER, LYFT Stocks Rise as California Court Rules Drivers Are Contractors ↗

March 14, 2023

Uber (UBER) and Lyft (LYFT) stock are on the rise Tuesday after a court ruled that the companies' drivers are contractors.

Via InvestorPlace

Why Is OKYO Pharma (OKYO) Stock Down 10% Today? ↗

March 14, 2023

OKYO Pharma (OKYO) stock is heading lower on Tuesday after the company revealed details of a stock offering for its ADSs.

Via InvestorPlace

Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 14, 2023

Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 14, 2023

Via Benzinga

Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket ↗

March 14, 2023

Gainers PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 14, 2023

We're starting off the day with an overview of the biggest pre-market stock movers investors need to keep an eye on for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 13, 2023

Via Benzinga

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

March 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

US Stocks Edge Lower; Dollar Tree Profit Beats Views ↗

March 01, 2023

U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 30 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.09% to 32,626.82 while...

Via Benzinga

Why Is Helbiz (HLBZ) Stock Up 37% Today? ↗

March 01, 2023

Helbiz (HLBZ) stock is on the move Wednesday despite a lack of hard news concerning the electric bike and scooter company.

Via InvestorPlace

XPEV Stock Alert: What to Know as Xpeng Reports February Vehicle Deliveries ↗

March 01, 2023

Xpeng (XPEV) stock is worth checking on Wednesday after the electric vehicle (EV) company released delivery data for February.

Via InvestorPlace

Why Is Novavax (NVAX) Stock Down 26% Today? ↗

March 01, 2023

Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business.

Via InvestorPlace

Why Is OKYO Pharma (OKYO) Stock Down 31% Today? ↗

March 01, 2023

OKYO Pharma (OKYO) stock is taking a beating on Wednesday despite recent progress toward a Phase 2 clinical trial for dry eye treatment.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.